Trademarkia Logo

Australia

AU$
Trademark Search
SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)

View On IPO.GOV.AU

SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)
Not protected: Not accepted

Last updated on 12 Jan 2022

Owner Info

Mezzion Pharma Co., Ltd.

C & H Building, 3rd Floor,

35 Teheran-ro 87-Gil,, REPUBLIC OF KOREA

Serial Number

2080622 filed on 14 Feb 2020

Correspondent

Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP

550 West Adams Street,

Chicago IL 60661,

UNITED STATES OF AMERICA

SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)

Classification Information

Class [041]
Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course mat Read More

Class [044]
Providing information in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues via a website; providing information relating t Read More

Mark Details

Serial Number

2080622

Registered On

NA

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
12th Jan 2022International Registration in Australia Refused correspondence sent
11th Jan 2022Status change to Lapsed/Not Protected
10th Apr 2021IRDA - Opposition Still Possible Notice correspondence sent
3rd Dec 2020Adverse Report (Examination) correspondence sent
2th Dec 2020IP Right Goods and Services Items updated
2th Dec 2020IP Right Goods and Services Items updated
2th Dec 2020IP right goods and service classes updated
2th Dec 2020IP Right has been Examined
13th Nov 2020Examination Response Received
21st Oct 2020Customer Amendment Made correspondence sent